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Background—Hispanics/Latinos are purportedly at increased risk for neurocognitive decline 
and dementias. Without dementia cures, low-cost, well-tolerated public health means for 
mitigating neurocognitive decline are needed.
Objective—We examined associations between neurocognition and cardiovascular health (CVH) 
metrics (Life’s Simple 7; LS7) among diverse Hispanics/Latinos. We hypothesized that higher 
LS7 would be associated with healthier brain function (neurocognitive performance).
Methods—We used baseline (2008–2011) Hispanic Community Health Study/Study of Latinos 
(HCHS/SOL; N = 9,623; ages 45–74 years) to examine neurocognition in relation to CVH LS7 
scores.
Results—In age and sex adjusted models, a one unit LS7 score increase (range = 0–14) was 
associated with higher neurocognitive function on the B-SEVLT sum (0.23 [p <0.01]; range = 3–
42), B-SEVLT recall (0.12 [p <0.01]; range = 0–15), Word Fluency (phonemic; 0.46 (p < 0.01); 
range = 0–49), and Digit Symbol Substitution (0.49 (p < 0.01); range = 0–83) tests, respectively. 
Stated differently, a change from the minimum LS7 (0) to maximum LS7 (14) score corresponded 
to higher scores on verbal learning (4.62) and memory (2.24), verbal fluency (7.0), and 
psychomotor processing speed (12). In fully adjusted models the associations were attenuated, but 
remained statistically significant. Incremental adjustments indicated that Latino background and, 
to a lesser extent, education were primary contributors to the evinced attenuations.
Conclusions—We found that higher neurocognitive function was associated with better LS7 
CVH metrics among middle-aged and older Hispanics/Latinos. Associations between 
neurocognitive function and LS7 were strongest among two at-risk groups for neurocognitive 
decline and dementia, women and Hispanics/Latinos with lower education. Public health efforts to 
reduce cardiovascular disease morbidity and mortality may have additional neurocognitive benefits 
among at-risk Hispanics/Latinos.
Keywords
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INTRODUCTION
“Staying sharp” into older adulthood is a major concern of most Americans. Driven by fear 
of Alzheimer’s disease and other dementias, loss of independence and self, many ask “what 
can I do to remain cognitively healthy into older adulthood?” In response, the Institute of 
Medicine (IOM) recently released a timely review with public health opportunities and 
recommendations for maintaining a cognitively “sharp” mind as the nation and global 
populations age [1]. In the context of this IOM report and state of science, [1, 2] we note that 
the brain consumes up to 20% of all cardiac output, about 20% of the body’s oxygen, and 
nearly 25% of glucose. Acute cerebral blood flow disruptions can have devastating and 
nearly immediate effects on tissue and function; while chronic insufficiencies have more 
insidious sequelae [3]. Thus, maintaining healthy brain vascular perfusion to demanding 
brain tissue is vital for its immediate survival and short- and longterm functional integrity. In 
this study, we examine neurocognitive function in relation to cardiovascular health (CVH) 
among middle-age and older Hispanics/Latinos.
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Hispanics/Latinos are reportedly at increased risk for neurocognitive decline and dementias 
compared to Whites [4]. Without cures for dementias on the near horizon, public health 
means for reducing risk for neurocognitive decline and dementias are being sought. Healthy 
cardiovascular lifestyles are increasingly recognized as neurocognitively beneficial and may 
provide neuroprotection and resilience to impairment [5, 6]. If so, improving population-
level cardiovascular health through modifiable lifestyles has the potential to mitigate the 
looming public health burden of Alzheimer’s disease and other dementias, especially among 
groups at high risk for these disorders [7].
In 2010, the American Heart Association (AHA) established national goals to improve 
Americans’ CVH by 20% while reducing cardiovascular diseases, deaths, and stroke by 20% 
by year 2020 [8]. Also known as Life’s Simple 7™ (LS7), the CVH goals include three 
behavioral (i.e., healthy diet, non-smoking, and physical activity) and four biomarker 
measures (i.e., blood pressure, body mass index, total cholesterol, and fasting blood 
glucose), each with quantified metrics [8]. Each of the seven components can be easily 
summarized into ranges indicative of “Ideal, Intermediate and Poor” CVH status. While few 
(<1%) Americans meet all seven “Ideal” CVH goals, equally few (about 2%) meet the 
“Poor” criteria [9–11]. Nevertheless, having more LS7s in the Ideal range is associated with 
better CVH, lowered cardiovascular disease incidence, and other adverse health outcomes 
[9, 12, 13]. Higher LS7 that are indicative of better CVH have been associated with more 
favorable neurocognitive function and lower incident neurocognitive impairment in African 
American and non-Latino White populations [5, 6].
The purpose of this study was to examine associations between neurocognitive function and 
LS7 CVH metrics among middle-aged and older Hispanics/Latinos. We hypothesized that 
higher LS7 would be associated with healthier brain function (neurocognitive performance). 
To achieve our study aims, we use baseline (2008–2011) data from the Hispanic Community 
Health Study/Study of Latinos (HCHS/SOL).
METHODS
Study sample
HCHS/SOL is a multiethnic, multisite, prospective cohort study of 16,415 community-
dwelling Hispanic/Latino adults (18- to 74-years old). We focused on the middle-aged and 
older cohort (45- to 74-years old; N = 9,623) with baseline neurocognitive assessment data. 
HCHS/SOL design was formulated to estimate representative baseline risk factors for 
overall Hispanic/Latinos as well as for specific backgrounds, including Central Americans, 
Cubans, Dominicans, Mexicans, Puerto Ricans, and South Americans. Data were collected 
from field centers in four U.S. cities with substantial Hispanic/Latino population 
concentrations (Bronx, NY; Chicago, IL; Miami, FL; and San Diego, CA). Each field center 
recruited about 4,000 eligible, self-identified Hispanic/Latino adults, and detailed 
HCHS/SOL sampling methods are available elsewhere [14, 15].
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Neurocognitive tests
Neurocognitive tests were administered in the participants’ preferred language during face-
to-face interviews by trained, bilingual research assistants. Four neurocognitive tests were 
used in this study: 1) Six-Item Screener (SIS); [16] 2) Brief-Spanish English Verbal 
Learning Test (B-SEVLT); [17, 18] 3) phonemic Word Fluency (henceforth, WF) test of the 
Multilingual Aphasia Examination; [19, 20] and (3) Digit Symbol Subtest test (DSS; also 
referred to as DST) [21]. These neurocognitive tests and scoring procedures have been 
previously described [22]. Briefly, the SIS (range 0–6) is a mental status test that was scored 
dichotomously with a value of 4 or lower representing “cognitive impairment”. The cutpoint 
reflects previous validation work in patients with dementia [16]. The B-SEVLT is an 
episodic learning and memory test with two scores: 1) the summed total correctly learned 
items across three learning trials (B-SEVLT-sum; range 0–45) and 2) total correctly recalled 
items (B-SEVLT recall; range 0–15) following an interference trial. WF is a verbal fluency 
test (continuous) of summed correctly generated words (beginning with letters F and A) 
within 1 minute. DSS is a mental processing speed exam that was continuous total of correct 
responses (range 0–90). Detailed descriptives of the distributions of the neurocognitive tests 
including means, standard deviations, medians, and percentiles (5th, 25th, 75th, and 95th) 
are provided in Supplementary Table 1. All four continuous measures were standardized 
(i.e., z-score transformed) to the population of interest to facilitate test scores comparisons 
and inferences.
Life’s Simple 7
CVH indicators including diet, physical activity, smoking, body mass index, blood pressure, 
cholesterol, and glucose were measured per AHA criteria and coded categorically as Ideal (2 
points), Intermediate (1 point), or Poor (0) [8]. We then calculated the sum of the seven LS7 
criterion scores (range 0–14) for each participant as previously published. Individual LS7 
indicator attributes are presented in Supplementary Table 2. A detailed presentation of the 
distribution of the LS7 indicators in HCHS/SOL target population has been previously 
published [23].
Covariates
Covariates included six demographic and socioeconomic indicators including: 1) age in 
years, and age squared (to accommodate the possibility of a curvilinear relationship between 
age and cognition), 2) sex, 3) Hispanic/Latino background (Dominican, Central American, 
Cuban, Mexican, Puerto-Rican, and South American), 4) education (<12-years; high school 
or equivalent; some college; and college or more), 5) household income (< = $20,000; 
$20,001–$50,000; >$50,000; and unreported; note that respondents with unreported income 
were included as an analytical category to avoid excluding observations from our analytical 
sample), and 5) language preference (Spanish/English). In additional analyses, we accounted 
for study site in the model to examine whether variations in locales can explain any reported 
associations between our primary predictor and outcomes.
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Analytic procedures
Data analytic procedures designed for complex survey sample designs in the Stata software 
package (12.1) were used to perform all study analyses, and appropriate methods for 
subpopulations analyses of complex survey data were applied to generate our estimates [24]. 
Specifically we used a Taylor Series Linearization approach to variance estimation to obtain 
correct standard errors [25]. We excluded respondents who did not report a specific Latino 
background from the analyses (n = 227). We also excluded respondents reporting prevalent 
stroke or transient ischemic attack diagnoses (n = 349). Finally, we excluded (n = 192) 
respondents with missing values on the model covariates. Our analytic sample consisted on 
n = 8,855 Hispanic/Latino participants. The study protocol was reviewed and approved by 
the institutional review boards at Michigan State University and all other participating sites.
Our data analyses were conducted in three steps. First, we generated analytic sample 
descriptive statistics for the variables of interest (Table 1). Additionally we characterized the 
distribution of our AHA LS7 predictor variable and grouped respondents in three categories: 
the lowest (i.e., 0–25th percentiles), Inter Quartile Range (IQR = >25th and <75th), and 
those in the highest (i.e., 75th to 100). Subsequently, we calculated descriptive statistics 
across the three generated categories, and tested for significant associations between our 
covariates and the above-mentioned categorical LS7 variable using survey adjusted chi-
squared tests (Table 1).
Second, we used survey linear regression models to test the associations between the 
continuous AHA LS7 indicator (range 0–14) and each of the standardized neurocognitive 
tests (Table 2). All analyses were re-executed using the original metrics of the 
neurocognitive tests and are available in Supplementary Table 3. We fit survey logistic 
regression models to test the association between LS7 and the dichotomous SIS outcome 
(i.e., low mental status score). In both the linear and logistic regression models, we started 
by testing unadjusted (bivariate) associations. Subsequently, we assessed how controlling for 
our covariates affected these associations by first adjusting for age and sex, and then 
controlling for Latino background, education, income, and language preference. The crude, 
age and sex, and fully adjusted models are presented in Table 2. Results of models using the 
original neurocognitive metrics are presented in Supplementary Table 3. Results of 
incremental adjustments to these covariates to examine the attenuation in associations 
between LS7 scores and each of the neurocognitive outcomes are included in Supplementary 
Table 4. In additional models (available from authors) we also accounted for Field Center 
site. Accounting for Field Center site did not notably affect the reported associations 
between the primary predictor and outcomes of interest and the Field Center covariate was 
excluded to maintain model parsimony. To facilitate the interpretation of our results, we 
calculated and plotted the marginal means of our standardized continuous outcomes, and 
marginal probabilities for the dichotomous SIS, across the continuum of LS7 index values 
for the unadjusted, age-sex adjusted, and fully adjusted regression models (Fig. 1). 
Additionally, we calculated and presented the estimated marginal means of the continuous 
neurocognitive outcomes in their original metric in Supplementary Figure 1.
Third, we separately tested for the differential nonadditive effects of age, sex, and education 
on the association between each of the neurocognitive tests and LS7 scores. We did so by 
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refitting the fully adjusted models (detailed in step 2 above) while accounting for 1) LS7 by 
age (measured using 3 groups; 1=45–54, 2 = 55–64, and 3 = 65+), 2) LS7 by sex, and 3) 
LS7 by education interactions. The interactions from model estimates are included in 
Supplementary Table 5. The interactions from model estimates models based on the original 
test metrics are included in Supplementary Table 6. Interaction effects are best understood 
when visualized [26]. Consequently, we calculated the marginal means (for the standardized 
neurocognitive tests) and probabilities (for the dichotomous SIS) resulting from the 
continuous by categorical interactions of LS7 with 1) sex, 2) age, and 3) education, and 
plotted the estimates and their 95% confidence interval bounds (Figs. 2, 3, and 4). For 
further clarity, we explicitly tested and plotted contrasts for the linear predictions resulting 
from these interactions (Supplementary Figures 5, 6, and 7). As with above, we recalculated 
and presented the estimated marginal means of the continuous neurocognitive outcomes in 
their original metric in Supplementary Figures 2–4.
RESULTS
Descriptive statistics
Survey weighted descriptive statistics for the overall analytic sample and by LS7 quartiles 
are presented in Table 1. Slightly more than half of our sample was female (55%), and the 
mean age was 56.3 years with close to half of respondents (47.3%) reporting ages between 
45–54 years. Mexican-origin was the largest Latino group (32.2%), followed by Cubans 
(27.8%), and Puerto Ricans (18%). Two-in-five respondents reported less than a high-school 
education (40.4%), and as many (45.7%) reported a household income of less than $20,000. 
Finally, the overwhelming majority of respondents (86.6%) chose Spanish as their preferred 
language.
The estimated means for the neurocognitive tests were 22.3 (standard deviation (SD) = 7.0), 
8.0 (SD = 3.6), 18.3 (SD = 8.9), and 33.8 (SD = 16.4) for the SEVLT Sum, SEVLT Recall, 
Word Fluency, and Digit Symbol Substitution, respectively. The estimated mean for the LS7 
index was 7.6 (SD = 2.5). Detailed descriptives for the outcomes and primary exposure 
variable are presented in Supplementary Table 1.
Crude associations between neurocognitive measures and LS7
Unadjusted linear regression models showed consistent significant positive associations 
between the neurocognitive outcomes and higher LS7 scores (Table 2, and Fig. 1). A one-
unit improvement in the LS7 index was associated with 0.05 (p < 0.001), 0.04 (p < 0.001), 
0.06 (p < 0.01), and 0.05 (p < 0.001) higher B-SEVLT Sum, B-SEVLT Recall, Word 
Fluency, and Digit Symbol Substitution standardized scores, respectively (the equivalent of 
0.33, 0.16, 0.5, and 0.86 units change under the original metric; Supplementary Table 3). 
Stated differently, these associations correspond to 4.62 B-SEVLT Sum, 2.24 B-SEVLT 
Recall, 7.0 Word Fluency, and 12.0 Digit Symbol Substitution higher points on the four 
tests, respectively, concomitant with a change from the minimum (score 0) to the maximum 
(score 14) on the LS7 index (Supplementary Figure 1). Similarly, the unadjusted logistic 
regression model indicated that higher LS7 scores indicative of better CVH were associated 
(OR = 0.90; 95% CI = 0.87–0.93) with decreased odds of low mental status scores (SIS< = 
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4). A difference in the probability of low mental status equivalent to 0.20, concomitant with 
a change from the minimum (score 0) to the maximum (score 14) on the LS7 index 
(Supplementary Figure 1).
Adjusted associations
Age and sex adjustments led to expected attenuations in the reported associations between 
neurocognitive function and LS7 scores (Table 2, and Fig. 1). These attenuations equaled 
30.1%, 29.4%, 8.5%, and 43% in the magnitude of the reported beta coefficients for the B-
SEVLT Sum, B-SEVLT Recall, Word Fluency, and Digit Symbol Substitution, respectively 
(Supplementary Table 4). However, all reported associations remained statistically 
significant (p <0.001), and this was consistent across all five neurocognitive domains 
considered. More specifically, after age and sex adjustments, a one-unit improvement in the 
LS7 index was associated with 0.03 (p < 0.001), 0.03 (p < 0.001), 0.05 (p < 0.01), and 0.03 
(p < 0.001) higher B-SEVLT Sum, B-SEVLT Recall, Word Fluency, and Digit Symbol 
Substitution standardized scores (Table 2), respectively (the equivalent of 0.23, 0.12, 0.46, 
and 0.49 units change under the original metric; Supplementary Table 3). These associations 
correspond to 3.22, 1.68, 6.44, and 6.9 higher points on the four tests, respectively, 
concomitant with a change from the minimum (score 0) to the maximum (score 14) on the 
LS7 index (Supplementary Figure 1). Additional adjustment for demographic and 
socioeconomic confounders further reduced the magnitudes of the reported relationships but 
did not completely attenuate their statistical significance (Table 2). Incremental adjustments 
indicated that Latino heritage and, to a lesser extent, education were primary contributors to 
the evidenced attenuations (Supplementary Table 4). Specifically, controlling for education 
led to additional attenuations that were equivalent to 16.4%, 14.2%, 17.3%, and 22.2% for 
the B-SEVLT Sum, B-SEVLT Recall, Word Fluency, and Digit Symbol Substitution, 
respectively. Controlling for Latino heritage further attenuated the associations by 23.2%, 
24.3%, 19.4% and 9.5%, respectively. After accounting for all covariates (Latino 
background, education, income, and linguistic preference) a one-unit improvement in the 
LS7 score was associated with 0.01 (p < 0.05), 0.01 (p < 0.05), 0.03 (p < 0.01), and 0.01 (p 
< 0.01) standard deviations increase in B-SEVLT Sum, B-SEVLT Recall, Word Fluency, and 
Digit Symbol Substitution tests, respectively (the equivalent of 0.08, 0.04, 0.25, and 0.18 
units change under the original metric; Supplementary Table 3). The attenuation in the odds 
ratios of the low mental status models were much smaller (Table 2). That is, the significant 
associations between low mental status and cardiovascular health (i.e., higher LS7 scores) 
were not markedly affected by the factors that we considered in this study. The fully 
adjusted logistic regression model indicated that LS7 scores remained negatively associated 
(OR = 0.93; 95% CI = 0.89–0.97) with low mental status (SIS< = 4). Figure 1 presents the 
expected means (in SD units) neurocognitive scores and probability of low mental status per 
unit change in the LS7 score resulting from the unadjusted and adjusted models detailed 
above. Supplementary Figure 1 presents the expected means (in tests metrics) 
neurocognitive scores per unit change in the LS7 score resulting from the unadjusted and 
adjusted models detailed above.
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Interaction effects
There was a significant multiplicative effect of sex on the association of LS7 with B-SEVLT 
recall (p = 0.004), and Word Fluency (p = 0.011). Specifically, neurocognitive function for 
female participants was more likely to significantly improve with higher LS7 scores 
compared to males, as evidenced by different slopes of the regression lines for females and 
males in Fig. 2. The interaction between age and LS7 scores were consistently statistically 
insignificant for all considered neurocognitive measures (similar regression lines slope in 
Fig. 3). We did not find consistent multiplicative effects for education (Fig. 4) on all 
neurocognitive outcomes. However, better LS7 scores were associated with improved 
SEVLT-Sum scores (p = 0.027) among respondents reporting less than high school 
education compared to those reporting high school or equivalent level of schooling and with 
higher SEVLT-recall scores (p = 0.028) among respondents reporting high school or 
equivalent level of schooling compared to those reporting college or more education. The 
predicted means for the interaction models using the cognitive tests metrics are presented in 
Supplementary Figures 3, 4, and 5 for the sex, age, and education interactions, respectively. 
To further facilitate the interpretation of the tested interactions and show specific regions of 
significance in differences, we plotted the contrasts in linear predictions resulting from these 
interactions across the LS7 score continuum for the age, sex, and education groups in 
Supplementary Figures 5, 6, and 7, respectively.
DISCUSSION
More than ever, middle-aged and older adults are interested and invested in maintaining their 
physical and neurocognitive health. Herein, we found that higher neurocognitive function 
was associated with better cardiovascular health among middle-aged and older Latinos of 
diverse backgrounds. The cross-sectional associations between neurocognitive function and 
higher or Ideal LS7s were substantial, and our findings are consistent with mounting 
evidence that cardiovascular health is important to neurocognitive function [27, 28]. Our 
study extends existing evidence to diverse and understudied Hispanic/Latino populations. 
The American Heart Association 2020 goals for reducing cardiovascular morbidity and 
mortality that were used in this study were associated with higher neurocognitive function. 
With the one exception of lifelong learning, AHA’s LS7 2020 goals overlap with brain 
health findings and initiatives of the Alzheimer’s Association [27, 29]. In principle, 
concerted heart and brain health efforts could yield high public health dividends for an 
increasingly diverse and older US population.
As US and global populations age, stroke and neurocognitive disorders (e.g., Alzheimer’s 
disease) will continue their ascension as leading causes of global and national disease 
burden unless effective public health prevention measures are implemented [30]. In the late 
19th and early 20th centuries, dementia was largely considered a consequence of brain 
vascular pathology, which was later overshadowed by intensified focus on neuronal 
etiologies [31, 32]. Now in the early 21st century, the boundaries between Alzheimer’s 
disease and related dementia etiologies are beginning to dissolve, [33] and there is renewed 
interest in brain vascular pathology that have important implications for brain disease 
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prevention. By extension, public health education and promotion campaigns to improve 
population-level CVH would likely have concomitant brain health effects.
Reis et al. reported that more favorable LS7s among African American and White youths in 
the Coronary Artery Risk Development in Young Adults (CARDIA) study followed over 25-
years were associated with better neurocognitive function in midlife [5]. Additionally, 
Thacker and colleagues demonstrated in the REasons for Geographic And Racial 
Differences in Stroke (REGARDS) study of African Americans and Whites that 
Intermediate and Ideal LS7 levels were associated with lower incident neurocognitive 
“impairment.” [6] Our HCHS/SOL study extends extant work to middle-aged and older, 
community-dwelling Hispanic/Latino adults. Our cross-sectional study is unique in that we 
demonstrated contemporaneous associations between neurocognition and LS7s, which is 
consistent with non-human work, [34] and further supports extant findings and assertions 
that higher levels of CVH (i.e., LS7) may have additional and more immediate 
neurocognitive functional benefits. Furthermore, these benefits appear to be consistent 
across multiple domains of neurocognitive health including mental status/orientation, 
episodic learning and memory, verbal fluency, and psychomotor speed.
We observed notably stronger associations between better neurocognitive function and LS7 
scores among women compared to men. This observation is noteworthy in that women are at 
higher risk for Alzheimer’s disease and related dementias than men, [35] and improved 
CVH health may have the added benefit of improving and maintaining neurocognitive 
function in women. Secondly, low education is an important dementia risk, and we observed 
that the strongest associations between neurocognitive measures of verbal episodic learning 
and memory and LS7s were among those at the lowest education levels compared to the 
other more educated groups. Indeed, our findings showed that low education participants 
with the highest LS7s levels statistically “caught up” with the neurocognitive learning and 
memory performance of Hispanics/Latinos with post-secondary education. This is important 
since Hispanics/Latinos have among the lowest high school completion rates in the US [36]. 
Thus, our HCHS/SOL findings indicated that among Hispanic/Latino adults increasing LS7s 
had the strongest neurocognitive effects among two groups at increased risk for decline and 
dementia, namely women and those with the lowest educational levels. Nevertheless, these 
neurocognitive associations with LS7 and education among Hispanics/Latinos warrant 
further investigation. Thirdly, the association between higher LS7 scores and better 
neurocognitive performance was not age differentiated. This suggests that improved 
cardiovascular health plays an equally important role in neurocognitive health of middle-
aged and older Latino adults. Middle-age is recognized as a vulnerable period for developing 
cardiovascular diseases and neurocognitive decline. Our findings indicate that better CVH 
was associated with higher neurocognitive function among midlife and older Hispanics/
Latinos age that could help foster healthy neurocognitive aging.
A limitation of our findings was that they were cross-sectional and that we did not ascertain 
neurocognitive decline or disorders (e.g., dementias). Thus, we are unable to determine if 
LS7s leads to better neurocognitive function or visa versa. Regardless of the associations’ 
true directionality, better understanding CVH and neurocognitive function relationships is 
warranted given the global health priority status of Alzheimer’s disease and related 
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dementias [7]. Secondly, the sex differences in neurocognitive learning and memory in 
relation to LS7 that we observed in this study are intriguing and merit additional and focused 
exploration. Overall Hispanic/Latino CVH compared favorably to Whites and other ethnic/
racial groups with the exception of higher cohort BMI [8, 10, 23]. As the prospective 
HCHS/SOL cohort advances from midlife to older age, we will monitor associations 
between CVH, neurocognitive function.
CONCLUSION
In this study, we found that higher neurocognitive function was associated with better 
cardiovascular health among middle-aged and older Hispanic/Latino HCHS/SOL 
participants. The newly established LS7 cardiovascular health goals were established in 
order to reduce cardiovascular morbidity and mortality by 20% by year 2020, but we 
observed immediate associations in neurocognitive health in this study that we anticipate 
would have long-term benefits for neurocognitive health and dementia prevention. We will 
follow the HCHS/SOL cohort to determine what effect higher LS7s have on CVH and 
neurocognitive health as the cohort advances in age into the coming decade. Given the rapid 
expansion of US Hispanics/Latinos, the population will continue to exert major influences 
on US economics, society and policies in coming decades. For the US to maintain its global 
position, it is vital for the nation to find affordable public health methods to maintain and 
improve Hispanic/Latino neurocognitive and cardiovascular health.
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Fig. 1. 
Estimated marginal means of standardized continuous neurocognitive outcomes and 
marginal probabilities of neurocognitive impairment (SIS< = 4) from the Hispanic 
Community Health Study/Study of Latinos. Note 1: The marginal means are based on 
survey linear regression models used to test the association between LS7 and each of the 
four continuous standardized neurocognitive tests (SEVLT Sum, SEVLT Recall, Word 
Fluency, and Digit Symbol Test). The marginal probabilities are based on survey logistic 
regression models used totest the association between LS7 and dichotomous SIS (< = 4). 
Note 2: M1 reports unadjusted (bivariate) associations. M2 controls for age and sex. M3 
includes additional controls for Latino background, education, income, and language 
preference.
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Fig. 2. 
Estimated marginal means of standardized continuous neurocognitive outcomes and 
marginal probabilities of neurocognitive impairment (SIS< = 4) by sex from the Hispanic 
Community Health Study/Study of Latinos. Note 1: The marginal means are based on 
survey linear regression models used to test the association between LS7 and the 
standardized continuous neurocognitive outcomes. The marginal probabilities are based on 
survey logistic regression model used to test the association between LS7 and dichotomous 
SIS (< = 4). Note 2: The estimated marginal means of neurocognitive function and 
probabilities of impairment result from fully adjusted models (controlling for age, Latino 
background, education, income, and language preference) with an interaction between LS7 
and sex.
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Fig. 3. 
Estimated marginal means of standardized continuous neurocognitive outcomes and 
marginal probabilities of neurocognitive impairment (SIS< = 4) by age groups from the 
Hispanic Community Health Study/Study of Latinos. Note 1: The marginal means (and 95% 
CI) are based on survey linear regression models used to test the association between LS7 
and the standardized continuous neurocognitive outcomes. The marginal probabilities (and 
95% CI) are based on survey logistic regression models used to test the association between 
LS7 and dichotomous SIS (< = 4). Note 2: The estimated marginal means of neurocognitive 
function and probabilities of impairment result from fully adjusted models (controlling for 
sex, Latino background, education, income, and language preference) with an interaction 
between LS7 and age.
González et al. Page 15
J Alzheimers Dis. Author manuscript; available in PMC 2017 June 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 4. 
Estimated marginal means of standardized continuous neurocognitive outcomes and 
marginal probabilities of neurocognitive impairment (SIS< = 4) by education groups in the 
Hispanic Community Health Study/Study of Latinos. Note 1: The marginal means (and 95% 
CI) are based on survey linear regression models used to test the association between LS7 
and the standardized continuous neurocognitive outcomes. The marginal probabilities (and 
95% CI) are based on survey logistic regression models used to test the association between 
LS7 and dichotomous SIS (< = 4). Note 2: The estimated marginal means of neurocognitive 
function and probabilities of impairment result from fully adjusted models (controlling for 
age, sex, Latino background, income, and language preference) with an interaction between 
LS7 and education.
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Table 2
Associations between AHA LS7 CVH indicator (range 0–14) and neurocognitive scores from the Hispanic 
Community Health Study/Study of Latinos
Model 1 Model 2 Model 3
SEVLT Sum
    b/se     b/se     b/se
 LS7 (0–14)
    0.05***     0.04***     0.01*
    0.01     0.01     0.01
SEVLT Recall
    b/se     b/se     b/se
 LS7 (0–14)
    0.04***     0.03***     0.01*
    0.01     0.01     0.01
Word Fluency
    b/se     b/se     b/se
 LS7 (0–14)
    0.06***     0.05***     0.03***
    0.01     0.01     0.01
Digit Symbol Test
    b/se     b/se     b/se
 LS7 (0–14)
    0.05***     0.04***     0.01**
    0.01     0.01     0.00
Cognitive Impairment
(SIS< = 4)
OR/95%CI OR/95%CI OR/95%CI
 LS7 (0–14)
    0.90***     0.92***     0.93**
    0.87,0.93     0.88,0.96     0.89,0.97
Note 1: Survey linear regression models were used to test the association between LS7 and each of the four continuous standardized neurocognitive 
tests (SEVLT Sum, SEVLT Recall, Word Fluency, and Digit Symbol Test). Survey logistic regression models to test the association between LS7 
and the dichotomous SIS outcome. Note 2: Model 1 reports unadjusted (bivariate) associations. Model 2 controls for age and sex. Model 3 includes 
additional controls for Latino background, education, income, and language preference. Note 3: b is the unstandardized beta coefficient and se 
stands for standard error. OR indicates odds ratio, and CI stands for confidence interval. Note 4: Life’s Simple 7 (LS7) CVH indicators were 
measured per AHA criteria and coded categorically as Ideal (2 points), Intermediate (1 point) or Poor (0). We then calculated the sum of the seven 
LS7 criterion scores (range 0–14) for each participant. Note 5: SEVLT stands for Spanish English Verbal Learning Test. SIS indicates Six-Item 
Screener.
*p <0.05;
**p < 0.01;
***p < 0.001.
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